Neuropsychological function and cerebral metabolites in HIV-infected youth

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 4, 2012, Pages 981-990

  Nagarajan, R ^a   Sarma, M K ^a   Thomas, M A ^a   Chang, L ^b   Natha, U ^c   Wright, M ^c   Hayes, J ^c   Nielsen Saines, K ^a   Michalik, D E ^d   Deville, J ^a   Church, J A ^e   Mason, K ^c   Critton Mastandrea, T ^c   Nazarian, S ^c   Jing, J ^c   Keller, M A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d MILLER CHILDREN S HOSPITAL   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Brain metabolites; Cognitive domains; Glutamate; HIV; MR Spectroscopy; Scyllo inositol

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; ASCORBIC ACID; ASPARTIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; INOSITOL; INTEGRASE INHIBITOR; LACTIC ACID; N ACETYLASPARTIC ACID; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; PROTEINASE INHIBITOR; TAURINE;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; ATTENTION; BLOOD TRANSFUSION; BRAIN LEVEL; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMOTOR ACTIVITY; RESPONSE TIME; RIGHT HEMISPHERE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; AMINO ACIDS; ASPARTIC ACID; BRAIN CHEMISTRY; CD4 LYMPHOCYTE COUNT; CHILD; COGNITION; FEMALE; FRONTAL LOBE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 84875858027     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9407-7     Document Type: Article

References (54)

1. 1H-MRS spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children. J Magn Reson Imaging 27:710-717
2. Becker LA (2011) Effect Size. http://www.uccs.edu/faculty/becker http://web.uccs.edu/lbecker/Psy590/es.htm.
3. Bisiacchi PS, Suppiej A, Laverda A (2000) Neuropsychological evaluation of neurologically asymptomatic HIV-infected children. Brain Cogn 43(1-3):49-52
4. Blanchette N, Smith ML, King S, Fernandes-Penney A, Read S (2002) Cognitive development in school-age children with vertically transmitted HIV infection. Dev Neuropsychol 21(3):223-241
5. Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333-348
6. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14:278-283
7. Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E (2002) Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naïve HIV patients. NeuroImage 17(3):1638-1648
8. Conners CK, Staff MHS (2000) Conners' continuous performance test II (CPT II) computer program for windows™ technical guide and software manual. Multi-Health Systems, Inc., North Tonawanda, NY
9. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IVD, Newman SP, Harrison MJG (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic and MR imaging findings. Radiology 188:119-124
10. Delis DC, Kaplan E, Kramer J (2001) Delis kaplan executive function system. The Psychological Corporation, San Antonio
11. Erdmann N, Tian C, Huang Y, Zhao J, Herek S, Curthoys N, Zheng J (2009) In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. J Neurochem 109(2):551-561
12. Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L (2010) Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging 32(5):1045-1053
13. Frias-Martinez F, Rajakumar N, Lis XS, Singhal A, Banakar S, Lipnick S, Verma G, Ramadan S, Kumar A, Thomas MA (2008) ProFit-based quantitation of cerebral metabolites using 2D-L-COSY at 3T. International Society of Magnetic Resonance in Medicine (ISMRM) Conference, Toronto, Canada, #691.
14. Gabis L, Belman A, Huang W, Milazzo M, Nachman S (2006) Clinical and imaging study of human immunodefriciency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy. J Child Neurology 21:486-490
15. Griffith HR, den Hollander JA, Stewart CC, Evanochko WT, Buchthal SD, Harrell LE, Zamrini EY, Brockington JC, Marson DC (2007) Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease. NMR Biomed 20(8):709-716
16. Gruetter R (1993) Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 29(6):804-811
17. Hassel B, Dingledine R (2006) In: Siegel GJ, Albers RW, Brady ST, Price DL (eds.) Basic neurochemistry, molecular, cellular, and medical aspects, 7 Edn, Chapter 15, Glutamate. 267-290. Academic Press, Elsevier.
18. Hinkin CK, Castellon SA, van Gorp WG, Buckingham SL et al (1998) Neuropsychological features of HIV disease. In: van Gorp WG, Buckingham SL (eds) A mental health practitioner's guide to the neuropsychiatric complications of HIV/AIDS. Oxford University Press, New York, pp 1-41
19. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group; HNRC Group (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3-16
20. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, Wolfson T, Velin R, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramson I, Group HNRC (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1(3):231-251
21. 1H magnetic resonance spectroscopy study at 4 Tesla. NMR Biomed 18(1):51-55
22. Keller MA, Venkatraman TN, Thomas A, Deveikis A, LoPresti C, Hayes J, Berman N, Walot I, Padilla S, Johnston-Jones J, Ernst T, Chang L (2004) Altered neurometabolite development in HIV-infected children, Correlation with neuropsychological tests. Neurology 62:1810-1817
23. Keller MA, Venkatraman TN, Thomas MA, Deveikis A, Lopresti C, Hayes J, Berman N, Walot I, Ernst T, Chang L (2006) Cerebral metabolites in HIV-infected children followed for 10 Months with 1H-MRS. Neurology 66:874-879
24. Koekkoek S, de Sonneville LM, Wolfs TF, Licht R, Geelen SP (2008) Neurocognitive function profile in HIV-infected school-age children. Eur J Paediatr Neurol 12(4):290-297
25. Lange T, Schulte RF, Boesiger P (2008) Quantitative J-resolved prostate spectroscopy using two-dimensional prior-knowledge fitting. Magn Reson Med 59(5):966-972
26. Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J, Langer M (1996) HIV-related metabolic abnormalities in the brain: Depiction with proton MR spectroscopy with short echo times. Radiology 199:805-810
27. Lopez-Villegas D, Lenkinski RE, Frank I (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 94(18):9854-9859
28. Lu D, Pavlakis SG, Frank Y, Bakshi S, Pahwa S, Gould RJ, Sison C, Hsu C, Lesser M, Hoberman M, Barnett T, Hyman RA (1996) Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 199:423-428
29. Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L (2006) Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). Dev Neuropsychol 30(2):633-657
30. Meyerhoff D, Fein G, Weiner M (1996) Elevated scyllo-inositol in adult human brain. Proceedings ISMRM, 4th Scientific Meeting, New York, p 954.
31. Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B (1990) Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 40:197-203
32. Mohamed MA, Barker PB, Skolasky RL, Selnes OA, Moxley RT, Pomper MG, Sacktor NC (2010) Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging 28(9):1251-1257
33. Möller HE, Vermathen P, Lentschig MG, Schuierer G, Schwarz S, Wiedermann D, Evers S, Husstedt IW (1999) Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 9(1):10-18
34. Nagarajan R, Sarma MK, Thames AD, Castellon SA, Hinkin CH, Thomas MA (2012) 2D MR spectroscopy combined with prior-knowledge fitting is sensitive to HCV-associated cerebral metabolic abnormalities. Int J Hepatol 2012:179365
35. Ogg RJ, Kingsley PB, Taylor JS (1994) WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 104(1):1-10
36. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR III, International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team (2009) Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 23(14):1893-1901
37. Pavlakis SG, Lu D, Frank Y, Bakshi S, Pahwa S, Barnett TA, Porricolo ME, Gould RJ, Nozyce ML, Hyman RA (1995) Magnetic resonance spectroscopy in childhood AIDS encephalopathy. Pediatr Neurol 12:277-282
38. Pavlakis SG, Lu D, Frank Y, Wiznia A, Eidelberg D, Barnett T, Hyman RA (1998) Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. Am J Neuroradiol 19(2):383-385
39. Sailasuta N, Shriner K, Ross B (2009) Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 22:326-331
40. Salvan A-M, Lamoureux S, Michel G, Confort-Gourny S, Cozzone PJ, Vion-Dury J (1998) Localized proton magnetic resonance spectroscopy of the brain in children infected with human immunodeficiency virus with and without encephalopathy. Pediatr Res 44:755-762
41. 13C-NMR. Magn Reson Med 39(2):313-316
42. Selnes OA, Galai N, Bacellar H, Miller EN, Becker JT, Wesch J, Van Gorp W, McArthur JC (1995) Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology 45(2):267-275
43. Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, Wilkins M, Nichols S, Mellins C, Usitalo A, Garvie P, Rutstein R, for the Pediatric HIV/AIDS Cohort Study (PHACS) Team (2012) Impact of HIV severity on cognitive and adaptive funtioning during childhood and adolescence. Pediatr Infect Dis J 31:592-598
44. Tardieu M, Mayaux MJ, Seibel N, Funck-Brentano I, Straub E, Teglas JP, Blanche S (1995) Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 126(3):375-379
45. Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B (2001) Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 46:58-67
46. Thomas MA, Hattori N, Umeda M, Sawada T, Naruse S (2003) Evaluation of two-dimensional L- COSY and JPRESS using a 3T MRI scanner: from phantoms to human brain in vivo. NMR Biomed 16(5):245-251
47. Viola A, Nicoli F, Denis B, Confort-Gouny S, Le Fur Y, Ranjeva JP, Viout P, Cozzone PJ (2004) High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism. MAGMA 17(1):47-61
48. Visalli V, Muscoli C, Sacco I, Sculco F, Palma E, Costa N, Colica C, Rotiroti D, Mollace V (2007) N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction. BMC Neurosci 8:106
49. Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, Rothstein JD, Volsky DJ (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312(1):60-73
50. Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SD, Emery S, Cooper DA, Altair Study Group (2010) Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis 50(6):920-929
51. Wolters PL, Brouwers P, Moss HA, Pizzo PA (1995) Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Pediatrics 95(1):112-119
52. Wright MJ, Woo E, Foley J, Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller EN, Hinkin CH (2011) Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. J Neuropsychiatry Clin Neurosci 23(3):324-331
53. Yeudall LT, Fromm D, Reddon JR, Stefanyk WO (1986) Normative data stratified by age and sex for 12 neuropsychological tests. J Clin Psychol 42(6):918-946
54. th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, Abstract 79.